Introducing PrEP Into HIV Combination Prevention - Kenya

NCT02755350 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2100

Last updated 2016-04-28

No results posted yet for this study

Summary

Daily oral PrEP will be delivered to men who have sex with men (MSM), female sex workers (FSWs) and young women (YW) as part of a defined package of HIV combination prevention intervention for 12 months in 5 sites in Kenya. The project will assess adherence, adverse events, side effects, user satisfaction, cost, facility preparedness and provider competencies. PrEP eligibility and screening tools for MSM, YW and FSWs will be piloted and validated. Pregnant women will be enrolled in a sub-group and followed through 12 months post- partum to measure mother and infant outcomes that include health status, birth outcomes, birth defects, risk behavior and PrEP adverse effects. With lessons from initial PrEP studies in West and Central Africa, this project will apply good participatory practice guidelines through 1) continuous engagement with communities of FSWs, YW and MSM and 2) development and use of a communication engagement and advocacy strategy that will provide correct information, address attitudes and concerns whilst increasing demand for PrEP uptake. The actual cost of delivering HIV combination prevention which includes PrEP will also be assessed and cost effectiveness modeled.

Conditions

Interventions

DRUG

Truvada

Daily oral PrEP will be provided to a cohort of 2100 participants (female sex workers, men who have sex with men and young women at high HIV risk) in Kenya. Baseline data will be collected from all participants at enrolment. PrEP users will be followed up at multiple intervals, in months 1, 4, 7, 10 and 12) for 12 months. The PrEP users will attend 7 visits at the project sites over the project period and in between these visits, they will return to the pharmacy for PrEP refill, adherence counselling and assessment of side effects.

Sponsors & Collaborators

  • Bill and Melinda Gates Foundation

    collaborator OTHER
  • Sex Workers Outreach Project

    collaborator UNKNOWN
  • National AIDS Control Council

    collaborator UNKNOWN
  • National AIDS and STI Control Programme

    collaborator UNKNOWN
  • Health Options for Young Men with AIDS/STI

    collaborator UNKNOWN
  • Bar Hostess Empowerment & Support Programme

    collaborator UNKNOWN
  • Gay and Lesbian Coalition Kenya

    collaborator OTHER
  • ISHTAR MSM

    collaborator UNKNOWN
  • Kenya Sex Workers Alliance

    collaborator UNKNOWN
  • London School of Hygiene and Tropical Medicine

    collaborator OTHER
  • Imperial College London

    collaborator OTHER
  • Results for Development

    collaborator UNKNOWN
  • O' Neill Institute

    collaborator UNKNOWN
  • AVAC

    collaborator UNKNOWN
  • Nyanza Western Kenya LGBTI Coalition

    collaborator UNKNOWN
  • World Health Organization

    collaborator OTHER
  • International AIDS Vaccine Initiative

    collaborator NETWORK
  • Centres for Disease Control and Prevention, Kenya.

    collaborator OTHER
  • LVCT Health

    lead OTHER

Principal Investigators

  • Serah N Njenga, BA · LVCT Health

  • Lawrence J Gelmon, MD.MPH · Sex Workers Outreach Project

  • Nduku S Kilonzo, PhD · National AIDS Control Council, Kenya

  • Helgar K Musyoki, MPH · National AIDS and STIs Control Program, Kenya

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-11-30
Completion
2017-04-30

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02755350 on ClinicalTrials.gov